Efficacy and Safety of Semaglutide for the Management of Obese Patients With Type 2 Diabetes and Chronic Heart Failure in Real-World Clinical Practice

Efficacy and Safety of Semaglutide for the Management of Obese Patients With Type 2 Diabetes and Chronic Heart Failure in Real-World Clinical Practice

BackgroundThe impact of glucagon-like peptide-1 receptor agonists on patients with heart failure has not been fully described. Our main objective was to evaluate the safety and clinical and glycemic efficacy of once-weekly semaglutide in obese patients with type 2 diabetes and heart failure.MethodsI...

Full description

Bibliographic Details
Main Authors: Luis M. Pérez-Belmonte, Jaime Sanz-Cánovas, María D. García de Lucas, Michele Ricci, Beatriz Avilés-Bueno, Lidia Cobos-Palacios, Miguel A. Pérez-Velasco, Almudena López-Sampalo, M. Rosa Bernal-López, Sergio Jansen-Chaparro, José P. Miramontes-González, Ricardo Gómez-Huelgas
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Endocrinology
Subjects:
obesity
type 2 diabetes
heart failure
semaglutide
health status
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.851035/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2022.851035/full

Similar Items